⚠️ This provider averages 1.1K services per working day — physically unusual for an individual practitioner
Based on 2.8M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $27.7M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 1.1K services per working day raises questions about billing patterns.
Medicare payments to this provider grew 60% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 107% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $21.65 | $7.32 | 2.96x | $14.33 | $2.3M | 309.0K | 37 |
| 2015 | $17.09 | $6.37 | 2.68x | $10.72 | $1.8M | 279.6K | 37 |
| 2016 | $25.34 | $9.67 | 2.62x | $15.67 | $3.7M | 380.8K | 42 |
| 2017 | $36.49 | $13.87 | 2.63x | $22.62 | $2.5M | 176.8K | 47 |
| 2018 | $34.75 | $10.72 | 3.24x | $24.03 | $2.5M | 237.7K | 50 |
| 2019 | $32.25 | $9.94 | 3.24x | $22.31 | $3.0M | 301.2K | 53 |
| 2020 | $36.88 | $10.99 | 3.36x | $25.89 | $3.0M | 268.9K | 57 |
| 2021 | $32.80 | $9.61 | 3.41x | $23.19 | $2.8M | 287.6K | 57 |
| 2022 | $32.27 | $9.52 | 3.39x | $22.75 | $2.7M | 282.8K | 55 |
| 2023 | $40.64 | $12.16 | 3.34x | $28.48 | $3.6M | 297.0K | 40 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 123.6K | $5.0M | $40.32 | 3.13x |
| J2505 | Injection, pegfilgrastim, 6 mg | 1.0K | $3.1M | $3.0K | 2.71x |
| J0897 | Injection, denosumab, 1 mg | 171.9K | $2.6M | $14.93 | 2.78x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 22.6K | $2.0M | $90.06 | 2.91x |
| J9310 | Injection, rituximab, 100 mg | 3.0K | $1.8M | $607.69 | 2.57x |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 50.3K | $1.7M | $34.67 | 2.99x |
| J2182 | Injection, mepolizumab, 1 mg | 70.0K | $1.6M | $23.09 | 3.56x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 135.1K | $1.1M | $8.40 | 2.62x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 7.8K | $869.1K | $111.60 | 3.31x |
| J9035 | Injection, bevacizumab, 10 mg | 14.3K | $811.0K | $56.70 | 2.52x |
| J9355 | Injection, trastuzumab, 10 mg | 9.0K | $706.7K | $78.37 | 2.52x |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 911.4K | $603.7K | $0.66 | 3.88x |
| J9305 | Injection, pemetrexed, 10 mg | 11.8K | $581.5K | $49.34 | 2.98x |
| J2469 | Injection, palonosetron hcl, 25 mcg | 26.5K | $327.9K | $12.38 | 3.98x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 35.0K | $315.9K | $9.02 | 3.67x |
| J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 367.9K | $286.7K | $0.78 | 2.59x |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 4.4K | $274.6K | $61.96 | 2.87x |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | 1.6K | $265.4K | $167.22 | 2.91x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 4.3K | $236.9K | $55.60 | 3.22x |
| J0517 | Injection, benralizumab, 1 mg | 1.7K | $231.1K | $132.83 | 3.21x |
This provider submits charges 3.1 times higher than what Medicare actually pays.
A markup ratio of 3.1x means for every $100 Medicare pays, this provider initially charges $310. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in FL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Christopher Lobo, MD | Port Charlotte, FL | $60.5M | ⚠️ Flagged |
| Maen Hussein, M.D. | Tavares, FL | $57.6M | ✓ Clear |
| Vikas Malhotra, M.D. | Spring Hill, FL | $52.8M | ✓ Clear |
| Andrew Lipman, M.D. | Naples, FL | $51.1M | ⚠️ Flagged |
| Syed Zafar, M.D. | Fort Myers, FL | $48.1M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data